drugset / Trial / NCT07603856
A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
Current clinical trials testing the combination of immunotherapy with radiotherapy.
Timeline
- Start
- 2026-12-12
- Primary completion
- 2030-06-25
- Completion
- 2030-06-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cemiplimab | Monoclonal antibody | — | — |
| Comparator | Docetaxel | Small molecule | — | — |
| Subject | Durvalumab | Monoclonal antibody | — | — |
| Comparator | Gemcitabine | Small molecule | — | — |
| Subject | Ipilimumab | Monoclonal antibody | — | — |
| Subject | Nivolumab | Monoclonal antibody | — | — |
| Subject | Pembrolizumab | Monoclonal antibody | — | — |
| Comparator | Ramucirumab | Monoclonal antibody | — | — |